Masimo Obtains CE Mark for SEDLine, Launches EEG-Based Brain Function Monitors in European Market
IRVINE, Calif., Aug. 24, 2011 /PRNewswire/ -- Masimo  (NASDAQ: MASI ) announced today that it has received CE Mark for its SEDLine brain function monitor — expanding access to and availability of SEDLine's advanced neuromonitoring technology to hospitals and clinicians across Europe. The only brain function monitor with four separate EEG channels in a single integrated algorithm SEDLine represents a critical advancement for the practice of anesthesia in Europe — more complete data for a more complete picture of brain function and sedation.
SEDLine expands the scope of real-time data and improves the management of an anesthetic case by enabling more individualized titration. Four channels of high-quality EEG data provide information about both sides of the brain to facilitate immediate detection of asymmetrical activity and yields a single sophisticated algorithm to give accurate, reliable information about a patient's response to anesthesia. Masimo's SEDLine Patient State Index (PSI™), a calculated measure of brain activity that reflects the patient's current level of sedation/anesthesia(1), provides additional data to enhance anesthetic control and facilitate rapid assessment. With demonstrated reliability under challenging clinical conditions and superior resistance to cautery(2), SEDLine offers a cost-effective solution for brain function monitoring that helps clinicians achieve targeted sedation throughout all phases of anesthesia — in the OR and ICU.
(Photo: http://photos.prnewswire.com/prnh/20110824/LA55746 )
According to Michael Ramsay, M.D., Chief of Anesthesiology and Pain Management & President of the Research Institute at Baylor University Medical Center in Dallas, Texas